Related Experiment Video
Updated: Mar 13, 2026

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
The redox paradox in HGGs: ROS as drivers and destroyers
Pooja Kumari1, Zacary P Germon1, Evangeline R Jackson1
1Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, New Lambton Heights, Newcastle, New South Wales, Australia; Precision Medicine and Health Program, Hunter Medical Research Institute, New Lambton Heights, Newcastle, New South Wales, Australia; Pediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine and Wellbeing, Callaghan, New South Wales, Australia.
Abstract:
Reactive oxygen species (ROS) are essential second-messenger molecules, yet when deregulated, they fuel cancer growth and therapeutic resistance. In high-grade gliomas, including glioblastoma, diffuse hemispheric glioma, and diffuse midline glioma (DMG), genetic, epigenetic, and metabolic alterations drive chronic ROS production and redox imbalance. This oxidative stress promotes DNA damage, epigenetic reprogramming, tumor growth, and immune escape. In DMG, global DNA and histone hypomethylation are amplified by oxidative stress, while ROS-dependent Ras/Raf/mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling pathways reinforce tumor survival. Paradoxically, the same ROS create an intrinsic vulnerability as excess ROS can overwhelm defenses and trigger cytotoxicity. Targeting ROS is challenging; however, new strategies, including NADPH oxidase inhibition, metabolic modulation, and ROS-inducing therapies, reveal vulnerabilities. Understanding this redox paradox is critical to exposing therapeutic vulnerabilities and improving outcomes for patients with these deadly cancers.
Insights
Reactive oxygen species (ROS) drive high-grade glioma growth and resistance. Targeting ROS reveals a paradox: they fuel tumors but also create vulnerabilities for new cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Reactive oxygen species (ROS) are crucial signaling molecules but their dysregulation fuels cancer progression and treatment resistance.
- High-grade gliomas, including glioblastoma, diffuse hemispheric glioma, and diffuse midline glioma (DMG), exhibit chronic ROS production due to genetic, epigenetic, and metabolic alterations.
- This sustained oxidative stress contributes to DNA damage, epigenetic changes, tumor proliferation, and immune evasion.
Purpose of the Study:
- To explore the dual role of ROS in high-grade gliomas, focusing on their contribution to tumor growth and therapeutic resistance.
- To investigate the specific mechanisms by which ROS impact DMG, including DNA/histone methylation and key signaling pathways.
- To identify therapeutic vulnerabilities arising from the paradoxical nature of ROS in cancer.
Main Methods:
- Review and synthesis of existing literature on ROS, oxidative stress, and high-grade gliomas.
- Analysis of genetic, epigenetic, and metabolic alterations contributing to ROS production in gliomas.
- Examination of ROS-dependent signaling pathways (MAPK, PI3K/Akt/mTOR) and their role in tumor survival.
- Evaluation of emerging therapeutic strategies targeting ROS, such as NADPH oxidase inhibition and metabolic modulation.
Main Results:
- Chronic ROS production and redox imbalance are hallmarks of high-grade gliomas, promoting tumor growth and resistance.
- In DMG, oxidative stress exacerbates global DNA and histone hypomethylation, while activating pro-survival pathways.
- Excess ROS paradoxically create an intrinsic vulnerability by overwhelming cellular defenses and inducing cytotoxicity.
- Targeting ROS through novel strategies like NADPH oxidase inhibition and metabolic therapies presents potential treatment avenues.
Conclusions:
- Understanding the complex redox paradox in high-grade gliomas is essential for developing effective therapeutic strategies.
- Exploiting the ROS-induced vulnerabilities offers a promising approach to improve outcomes for patients with these aggressive brain tumors.
- Further research into ROS-modulating therapies is critical for overcoming treatment resistance and enhancing patient survival in high-grade gliomas.
More Related Videos
Related Concept Videos
Proteoglycans
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Protein Glycosylation
Glycosylation occurs in...
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Protein Modifications in the RER
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Protein Folding Quality Check in the RER

